Freemont Management »

Regeneron Pharmaceuticals shares owned by Freemont Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Freemont Management from 13F filings

Historical chart of Freemont Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Freemont Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Freemont Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.1M 6.6k 771.87

More positions owned by Freemont Management

NVIDIA Corporation Common Stock (NVDA)
Arista Networks Common Stock (ANET)
Alphabet Class A Common Stock (GOOGL)
Teradyne Common Stock (TER)
IQVIA Holdings ETD Equity Option Call Option
Astera Labs Common Stock (ALAB)
Broadcom Common Stock (AVGO)
Waters Corporation Common Stock (WAT)
Cadence Design Systems Common Shares (CDNS)
Apple Common Stock (AAPL)
Autodesk Common Stock (ADSK)
Microsoft Corporation Common Stock (MSFT)
Fabrinet Ordinary Shares (FN)
Wheaton Precious Metals Corp. Common Stock (WPM)
Tesla Common Stock (TSLA)

View all positions for Freemont Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management
Nuveen

View all funds holding Regeneron Pharmaceuticals